France opens probe into systemic failures behind paedophile surgeon's decades of child abuse
A French court in May sentenced retired doctor Joël Le Scouarnec to 20 years in prison after he confessed to sexually abusing or raping 298 patients between 1989 and 2014.
Of those, more than 250 victims were under 15.
Victims and child rights advocates say the case highlights systemic flaws that allowed Le Scouarnec to repeatedly commit sexual crimes.
Le Scouarnec has been in prison since a court convicted him in 2020 of abusing four children, including two of his nieces.
Stephane Kellenberger, prosecutor in the western city of Lorient, said he had ordered an investigation last month into any failures to prevent the crimes.
The new probe by an investigating magistrate, which follows a preliminary probe ordered in 2020, would be able to include any relevant elements from the latest trial.
An AFP investigation published before the trial showed Le Scouarnec practised medicine for years despite a 2005 sentence for owning sexually abusive images of children, and both a colleague and a regional hospital official reporting him as unfit to practise.
When Le Scouarnec was promoted in 2006, his criminal record did not appear to have been updated and was still blank, according to documents from local and regional health agencies, AFP reporting found.
Following a regional investigation into a suspicious death at the hospital where he worked, Le Scouarnec moved to the southwest of the country.
Investigators only uncovered his alleged crimes after he retired in 2017, when a six-year-old girl accused him of rape and police found countless accounts of abuse in his diaries.
During the trial, the National Order of Physicians – a civil party in the case – said it "regretted" what it described as "dysfunctions" that allowed him to continue to practise.
A collective of the former surgeon's victims said a telephone hotline was launched on Thursday to provide support to victims, relatives and professionals who have followed the case.
Investigators are also looking into whether there are more victims.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Local France
4 hours ago
- Local France
'Witnesses to despair': Marseille sees poverty fuel cocaine problem
The scene, on the central Belsunce Square near the busy Old Port, plays out daily, an illustration of the second-biggest French city's massive drug problem. On pavements, in doorways and in parking lots, more users than ever can be seen shooting up cocaine or smoking crack. Many aimlessly wander the streets of the Mediterranean port city, which became notorious decades ago for its role as a heroin hub in the so-called "French connection" trade route, and today cannot get a grip on a thriving narcotics business. At lunchtime, a man lay sprawled on the street outside the parking lot of a shopping centre, two needles sticking out of his right arm. "You see more and more young people and women," said Youcef Mahi, a janitor. "I'm not judging. We are witnesses to despair." Crack 'drives you crazy' The city's budget for cleaning up after the addicts has risen six-fold to reach €152,000 ($177,000) this year, outweighing public subsidies for NGOs dedicated to reducing risks for drug users. But Antoine Henry, who runs the ASUD association to keep addicts safe, said more money should be funnelled into projects such as his. By his estimates, "2,000 users live in the streets of central Marseille, most of them without a home or income, often carrying infections, with no access to benefits, and sometimes undocumented." He said the sharp increase is partly due to overall rising poverty in what is already France's lowest-income large city, with the proliferation of downtown dealing spots over the past two years also to blame. Such spots are outposts of the main dealing rings located in low-income housing estates, and closer to socially vulnerable consumers who buy their cocaine there, usually for €10 ($11.60) a pop. On one Marseille street, a young lookout, called "chouf" (Arabic for 'look'), had taken up his post, only a few dozen metres from the main Canebiere thoroughfare and its municipal police headquarters. One 36-year-old woman, who did not want to be identified, told AFP that she lives in the street, except when she is in prison. She was seriously ill, shivering below her parka despite the hot July sun. She shoots cocaine, but does not smoke crack because, she said, "that drives you crazy". She said she tries to stay clear of police and doctors, but also of dealers and their gangland fights and shootouts. Marseille and its surrounding region are plagued by a turf war over lucrative drug points. In 2023, 49 deaths linked to drug trafficking were recorded in Marseille in connection with gang warfare, and 24 in 2024. Advertisement Clean syringes, rapid tests Joachim Levy regularly seeks out the woman when he and his colleagues from the Nouvelle Aube (New Dawn) association roam the streets in search of people in need of help. He has constantly urged her to accept treatment. "Otherwise you're going to die here," he said. At the foot of a building, a small group, like dozens of others in the neighbourhood, was cooking crack and crushing pills. In contrast to Paris, crack is rarely sold ready to consume here. Instead, users concoct it themselves by heating cocaine with ammonia. From his backpack, Levy handed out sealed syringes, pipes, disinfectant wipes and bicarbonate, which he said is "less harmful" than ammonia. A few streets away, a team from Nouvelle Aube were talking with men sheltering under the A7 highway. "We offer rapid testing for HIV and hepatitis -- and direct them to the hospital if needed. They no longer have their own survival strategies," said Marie-Lou, a member of the association who did not give her surname. Advertisement 'Poverty, isolation' A young woman, wearing glittery sneakers, a tight skirt and a handbag, turned a staircase corner. She told Levy about her mounting debt and her temporary accommodation with her child "at an ex's place". She used to smoke, and "snort a little", but then she turned to crack and soon realised she "was hooked". Levy told the woman "to call anytime". The biggest problem for people in her situation, he said, is not the actual drug use. "It's the poverty, the isolation, the street violence, the mental health issues -- this is where we need to start," he said. Levy believes supervised consumption facilities -- spaces where users can take their drugs safely -- could be "an excellent solution" to some of these issues. Such "shoot-up rooms", as critics often call them, operate in several countries, including Germany, Norway, the Netherlands and Australia. Advertisement No 'shoot-up room' Perrine Roux is research director at the INSERM health and medical research body, which has published an evaluation of France's only two experimental facilities in Paris and Strasbourg. "All scientific studies, in France and abroad, have shown the usefulness of such facilities," she said. "But nobody pays much attention to science, and that's very concerning." The interior ministry shut down a plan to open such a facility in Marseille after complaints from some residents and local politicians. On Thursday, the regional prefect announced an action plan against drug trafficking and related crimes, involving the deployment of additional police and anti-riot units "to give the dealing points a pounding", and of 310 extra security cameras. Meanwhile in Belsunce Square, the water fountain has stopped working, a fact welcomed by one resident. "Now that there's no water for them anymore, we may see less of the druggies," she said.
France 24
14 hours ago
- France 24
Moldova ex-minister charged in Interpol corruption case
French prosecutors say they suspect a multinational group of conspirators paid millions of dollars to public officials to sabotage Interpol red notices issued against selected suspects. Vitalie Pirlog, who chaired the commission controlling Interpol's files, was arrested on Tuesday in the United Arab Emirates on the basis of an international arrest warrant issued by France. He was extradited to France on Friday on charges including organised fraud and evading arrest, said the source, confirming a report in the French daily, Le Monde. Another source close to the case said Pirlog was suspected of having helped suspects get asylum-seeker status in Moldova so as to force the suspension of their red notices. Red notices are international alerts for suspected criminals. Pirlog's lawyer, Emmanuel Marsigny, told AFP the French arrest warrant was "incomprehensible" as his client had given the French financial prosecutors his address in the UAE. He had been waiting to be summoned for questioning as provided for by international conventions, he added. "Mr Pirlog is certainly not someone who wanted to evade justice -- quite the contrary," said Marsigny. Interpol said that after it had detected an attempt to "block and delete red notices" in a small number of cases, it had reported the matter to the authorities in France. The French authorities in early 2025 opened an investigation into suspected corruption within Interpol. The international law enforcement agency's headquarters are based in Lyon, southeast France. French financial prosecutor Jean-Francois Bohnert said his team suspected a group of people of different nationalities had bribed certain officials to block and delete red notices targeting certain fugitives. The sums involved could run to several million dollars, he added.
AFP
14 hours ago
- AFP
Health influencer falsely claims nicotine can cure neurological disorders
"Nicotine is not addictive. Parkinson's disease can be prevented and can be cured, and its symptoms reversed, with nicotine alone," health influencer Byran Ardis says in a video teasing an episode of the "Culture Apothecary" podcast from Alex Clark, a leading voice in the "Make America Healthy Again" movement. Ardis, whom AFP has previously fact-checked for spreading health misinformation, goes on to claim: "Nicotine is known by medical science to be a curative agent and a preventative agent for Alzheimer's. Did you know nicotine could also cure the symptoms of hypothyroidism?" He also asserts that "glioblastomas were proven in 2021 to be cured by nicotine alone." The clip has attracted tens of thousands of interactions on Instagram since May 19, 2025. Ardis's endorsement of nicotine patches continued to be shared across platforms in July, alongside other edits of the conversation, including one Clark posted on YouTube. Image Screenshot from Instagram taken July 18, 2025 But nicotine is an addictive chemical, and the only use for nicotine patches approved by the US Food and Drug Administration (FDA) is to quit smoking (archived here and here). "Don't use nicotine, other than trying to help quit smoking," Edward Levin, chief of the Neurobehavioral Research Lab at Duke University Medical Center, told AFP July 14 (archived here). He said the effect of nicotine on cognition, depression, Parkinson's or Alzheimer's "has not been proved, so it's still under investigation." Parkinson's disease In the podcast, Ardis claims nicotine by itself can prevent, cure or reverse symptoms of Parkinson's disease. Scientists are exploring nicotine's potential as a Parkinson's treatment due to the chemical's dopamine-increasing properties and the fact that smokers develop Parkinson's at a lower rate, but research has yielded mixed results (archived here). "Nicotine does potentially up the release of dopamine, and dopamine is what is impaired in Parkinson's disease. So the rationale for it is there, but the proof of it is not," Levin said. "To say flat out that it does prevent or cure Parkinson's just is not true." A 2015 study by the Parkinson's Institute concluded that nicotine could hold promise in terms of protecting against nerve degeneration, alleviating symptoms and reducing side effects of other drugs used to treat the disease (archived here). However, the study stops short of recommending nicotine as a proven treatment, saying instead that it "may represent a new disease modifying approach." A 2021 literature review published in Molecular Medicine Reports said nicotine may slow the progression of the disease by improving memory impairment and dyskinesia (archived here). Conversely, a trial supported by the Michael J. Fox Foundation showed nicotine patches did not slow the progression (archived here). "Despite some initially promising findings from animal models and correlational studies in humans, this has not translated well to clinical trials," Maggie Sweitzer, an associate professor in psychiatry and behavioral sciences at Duke University, told AFP in a July 15 email (archived here). "I am not aware of any solid evidence to support nicotine as a treatment in Parkinson's disease." Alzheimer's disease Ardis's second claim is that nicotine is "known by medical science" to be a curative and preventative agent for Alzheimer's disease. Researchers in the United States are currently investigating the effects of nicotine on mild cognitive impairment, a precursor to Alzheimer's, as part of the "Memory Improvement Through Nicotine Dosing" (MIND) study (archived here). But nicotine has not been incorporated into human treatment beyond clinical trials. A 2012 trial focused on 67 subjects concluded that nicotine led to cognitive improvement in attention, memory and processing, but it said further study would be necessary to determine if the findings were clinically important (archived here). A much larger follow-up is currently in progress, with results expected later in 2025 (archived here). Levin, a researcher on the MIND study, said despite promising findings, nicotine patches have not yet been FDA approved to protect against cognitive decline. "I can't recommend it," Levin said. "It's not FDA approved for that purpose. It's under investigation." Levin said that if nicotine patches were implemented as a treatment for Alzheimer's or other cognitive diseases, they would likely be used alongside other drugs, rather than alone. He also pushed back on Ardis's claim that it is safe to place nicotine patches on children, saying the drug is toxic from early fetal development through adolescence and can adversely impact the nervous system (archived here). Glioblastoma Ardis then claims nicotine alone was proven in 2021 to cure glioblastoma, an aggressive form of brain cancer. AFP did not find a reference with such clear proof. Instead, a 2021 paper in Pharmacological Research showed nicotine can promote the proliferation of glioblastoma cells, with nicotinic receptors potentially contributing to the tumor's aggressive behavior (archived here). The paper also discovered that drugs that block nicotinic receptors can decrease glioblastoma cell growth. An earlier literature review said smoking and other uses of tobacco and nicotine during treatment can detrimentally affect a patient's prognosis (archived here). Keyword searches did reveal a 2022 in vivo study which found that nicotine, in conjunction with lithium carbonate, can suppress and kill glioblastoma cells, although the study also warns of health risks resulting from nicotine's cytotoxicity (archived here). But such findings have not been replicated outside of in vivo cell studies, and Sweitzer said it would be difficult to study the isolated effect of nicotine on glioblastoma in a clinical setting. "It would be unethical for researchers to assign patients with glioblastomas to a treatment condition where they received 'nicotine alone' in the absence of usual standard of care, because this would deprive the patients of treatment that they would receive if they were not in the study," Sweitzer said. "In general, people should be highly skeptical about claims that something has been 'proven' in health and medicine." Lead Stories and Medical Dialogues previously debunked claims by Ardis that nicotine can cure brain tumors in as little as 72 hours. Hypothyroidism Finally, Ardis poses that nicotine could cure symptoms of hypothyroidism, a thyroid gland condition that can lead to high cholesterol and heart problems. The 2021 Molecular Medicine Reports literature review said nicotine may "activate thyroid receptor signaling pathways" to improve hypothyroidism-induced memory impairment (archived here). But Sweitzer said Ardis's claim misleads. "There are interactions between nicotine and thyroid hormones that have been clearly demonstrated in animal models," Sweitzer said (archived here and here). "But I am not aware of any evidence that would suggest nicotine can be used as a treatment in itself." Rexford Ahima, director of the division of endocrinology, diabetes and metabolism at Johns Hopkins University, agreed (archived here). "Nicotine does not cure hypothyroidism," Ahima told AFP in a July 15 email. "Nicotine use, especially through smoking, is linked to worsening of autoimmune hyperthyroidism." AFP has debunked other health misinformation here.
